Sanofi reported weighing higher Genzyme offer

PARIS/LONDON (Reuters) – Sanofi-Aventis is considering whether to raise its $18.5 billion bid for U.S. drugmaker Genzyme as soon as next week, Bloomberg said on Wednesday, citing people with knowledge of the matter.

Leave a Reply